(Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients. 04, 2022 (GLOBE NEWSWIRE) - RAPT Therapeutics, Inc. Morgan Healthcare Conference SOUTH SAN FRANCISCO, Calif., Jan. Considering analysts have assigned the stock a price target range of 49.00-72.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be 60.29. RAPT Therapeutics to Present at the 40th Annual J.P. This suggests a possible upside of 104.4 from the stocks current price. (NASDAQ:RAPT)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 2.25. On average, they expect RAPT Therapeutics stock price to reach 60.29 in the next twelve months. Their forecasts range from 49.00 to 72.00. SG Americas Securities LLC owned approximately 0.54 of RAPT Therapeutics worth. The Company is also pursuing a range of targets that are in the discovery stage of development. 7 equities research analysts have issued 1-year price objectives for RAPT Therapeutics stock. The firm owned 160,250 shares of the company’s stock after buying an additional 86,484 shares during the period. RAPT has discovered and advanced two unique drug candidates, FLX475 and RPT193, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of cancer and inflammation, respectively. RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold missionto conquer cancer and inflammatory disease in our lifetime.
#Rapt therapeutics stock drivers
Utilizing its proprietary discovery and development engine, the Company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. Free forex prices, toplists, indices and lots more. This worrisome indicator is a canary in the coal mine for stock-market tops MarketWatch. RAPT Therapeutics (RAPT) stock price, charts, trades & the USs most popular discussion forums. RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. RAPT Therapeutics started at overweight with 61 stock price target at J.P. If you had invested in RAPT Therapeutics stock at 12.70, your return over the last 2 years would have been 133.07, for an annualized return of 52. Sector Professional, Scientific, and Technical Services stock was originally listed at a price of 12.70 in Nov 1, 2019.Industry Research and Development in Biotechnology.In the short term (2weeks), RAPTs stock price should underperform the market by -3.25.During that period the price should oscillate between -11.33 and +9.63. 2, 2021 when the stock price was at 35.76. This means that this stock is suited as a new addition to your portfolio as trading bullish markets is always a lot easier. RAPT stock forecast Our latest prediction for RAPT Therapeutics Incs stock price was made on the Sept. This means that if you invested $100 now, your current investment may be worth 243.146$ on 2023 January 28, Saturday. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks.įuture price of the stock is predicted at 48.920982827261$ ( 143.146% ) after a year according to our prediction system. SOUTH SAN FRANCISCO, Calif., J(GLOBE NEWSWIRE) - RAPT Therapeutics, Inc. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if RAPT could be a good portfolio addition. RAPT Therapeutics (RAPT) skyrockets 100 on positive RPT193 data in early-stage atopic dermatitis study. RAPT Therapeutics stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Over the next 52 weeks, RAPT Therapeutics Inc has on average historically risen by 28.8 based on the past 2 years of stock performance. RAPT Therapeutics Stock Soars As Atopic Dermatitis Candidate Shows Promising Action In Early-Stage Study. stock forecastĪs of 2022 January 28, Friday current price of RAPT stock is 20.120$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). 1 year RAPT Therapeutics Forecast: 48.920982827261 *ĥ year RAPT Therapeutics Forecast: 275.137 * About the Rapt Therapeutics, Inc. (NASDAQ: RAPT) stock closed at 29.6 per share at the end of the most recent trading day (a 0.37 change compared to the prior day closing price) with a volume of 260.29K shares and market capitalization of a component of indices and it is traded on NASDAQ exchange. RESTRICTED STOCK UNIT GRANT NOTICE (2019 EQUITY INCENTIVE PLAN) RAPT Therapeutics, Inc.
0 kommentar(er)
